Literature DB >> 16807483

A work in progress: the metabolic syndrome.

Jose A Luchsinger1.   

Abstract

Metabolic syndrome refers to a constellation of risk factors for cardiovascular disease. They include elevated plasma glucose concentrations, dyslipidemia, hypertension, and abdominal obesity. These conditions typically occur during middle age or later in life. Although there is no clear consensus on the diagnosis of metabolic syndrome, it is a potentially important entity to recognize and manage once traditional cardiovascular risk factors, such as smoking, hypertension, dyslipidemia, and diabetes, have been treated individually. This Perspective summarizes our current knowledge of the metabolic syndrome. Lifestyle change, including diet and exercise, is probably the best available option for treating the metabolic syndrome. However, rigorous lifestyle interventions are difficult to implement outside of a clinical trial setting, especially among elderly patients.

Entities:  

Mesh:

Year:  2006        PMID: 16807483     DOI: 10.1126/sageke.2006.10.pe19

Source DB:  PubMed          Journal:  Sci Aging Knowledge Environ        ISSN: 1539-6150


  13 in total

1.  Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.

Authors:  Daniel Herranz; Maribel Muñoz-Martin; Marta Cañamero; Francisca Mulero; Barbara Martinez-Pastor; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  Nat Commun       Date:  2010-04-12       Impact factor: 14.919

2.  Type 2 diabetes and ethnic disparities in cognitive impairment.

Authors:  James M Noble; Jennifer J Manly; Nicole Schupf; Ming-Xing Tang; José A Luchsinger
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

3.  Exposure to light at night accelerates aging and spontaneous uterine carcinogenesis in female 129/Sv mice.

Authors:  Irina G Popovich; Mark A Zabezhinski; Andrei V Panchenko; Tatiana S Piskunova; Anna V Semenchenko; Maragriata L Tyndyk; Maria N Yurova; Vladimir N Anisimov
Journal:  Cell Cycle       Date:  2013-05-06       Impact factor: 4.534

Review 4.  New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases.

Authors:  Adeeb Shehzad; Taewook Ha; Fazli Subhan; Young Sup Lee
Journal:  Eur J Nutr       Date:  2011-03-27       Impact factor: 5.614

Review 5.  Adiposity and Alzheimer's disease.

Authors:  Jose A Luchsinger; Richard Mayeux
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

6.  Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years.

Authors:  José A Luchsinger; Rafi Cabral; Joseph P Eimicke; Jennifer J Manly; Jeanne Teresi
Journal:  Psychosom Med       Date:  2015 Jul-Aug       Impact factor: 4.312

Review 7.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

8.  Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats.

Authors:  Irina A Vinogradova; Vladimir N Anisimov; Andrey V Bukalev; Anna V Semenchenko; Mark A Zabezhinski
Journal:  Aging (Albany NY)       Date:  2009-10-02       Impact factor: 5.682

Review 9.  Adiposity, type 2 diabetes, and Alzheimer's disease.

Authors:  José A Luchsinger; Deborah R Gustafson
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Metabolic syndrome and dementia risk in a multiethnic elderly cohort.

Authors:  Majon Muller; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-18       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.